Acute Postpartum Pulmonary Edema: A Case Report

Similar documents
Tocolytics. Tocolytics (terbutaline, magnesium sulfate injection) Description

Critical Care in Obstetrics: An Innovative and Integrated Model for Learning the Essentials

By Dr.Asmaa Al sanjary

Maternal And Fetal Outcome In Pregnancies Complicated With Maternal Cardiac Diseases: Experience At A Tertiary Care Hospital

cardiovascular events when in use in these indications and the outcome of the review is summarised below.

Peripartum Cardiomyopathy. Lavanya Rai Manipal

Index. Note: Page numbers of article titles are in boldface type.

CARDIAC PROBLEMS IN PREGNANCY

CASE DISCUSSION. Dr JAYASREE VEERABOINA 2nd yr PG MS OBG

The Effect of Valvular Heart Diseases on Maternal and Fetal Outcome of Pregnancy Nada Salih Ameen*,Nawfal Fawzi Anwer**

Maternal and Fetal Physiology

Kofinas Perinatal Providing Care to the Unborn

PERIPARTUM CARDIOMYOPATHY

ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) Rv

Pregnancy outcomes in women after an arterial switch operation for transposition of the great arteries

Valve Disease in the Pregnant Patient

Pheochromocytoma Crisis Presenting as Fulminant Cardiopulmonary Failure: A Case Report

How to Recognize a Suspected Cardiac Defect in the Neonate

Policy REVISED: 6/30/2016 3:30 PM. Applies To: ObGyn Responsible Department: ObGyn Revised: June 30, 2016

Medical Complications of Pregnancy

Cardiac disease in pre pr gnancy

CHAPTER 12 HYPERTENSION IN SPECIAL GROUPS HYPERTENSION IN PREGNANCY

Susan P. D Anna MSN, APRN BC February 14, 2019

Maternal Cardiac Disease In Pregnancy. August 25, 2017 PREGNANCY ECHO CONFERENCE

Simultaneous Bilateral Spontaneous Pneumothorax: A Case Report

Drugs used in obstetrics

Reversible peripartum cardiomyopathy in a triplet pregnancy

Protocol Identifier Subject Identifier Visit Description. [Y] Yes [N] No. [Y] Yes [N] N. If Yes, admission date and time: Day Month Year

Acute Pulmonary edema Secondary to CARDIAC FAILURE NON COMPACTED LEFT VENTRICLE in Pregnancy

SWISS SOCIETY OF NEONATOLOGY. Prenatal closure of the ductus arteriosus

Lecture Notes. Chapter 9: Smoke Inhalation Injury and Burns

More History. Organization. Maternal Cardiac Disease: a historical perspective. The Parturient with Cardiac Disease 9/21/2012

Maternal Cardiac Disease Diagnosis and Management

When is Risky to Apply Oxygen for Congenital Heart Disease 부천세종병원 소아청소년과최은영

Hyaline membrane disease. By : Dr. Ch Sarishma Peadiatric Pg

Efficacy and side effect of ritodrine and magnesium sulfate in threatened preterm labor

Preterm Labour and Tocolysis

Maternal Collapse Guideline

CARDIOVASCULAR DISEASE ASSESSMENT IN PREGNANT AND POSTPARTUM WOMEN

1st Annual Clinical Simulation Conference

Peripartum kardiomyopati

Lecture Notes. Chapter 2: Introduction to Respiratory Failure

Review of Neonatal Respiratory Problems

Images in Cardiovascular Medicine

Infection. Risk factor for infection ACoRN alerting sign with * Clinical deterioration. Problem List. Respiratory. Cardiovascular

Patient Management Code Blue in the CT Suite

CEDR 2018 QCDR Measures for CMS 2018 MIPS Performance Year Reporting

Restrictive Cardiomyopathy in Cats (a Type of Heart-Muscle Disease) Basics

Peripartum Cardiomypathy: A five year hospital-based analytical study

AF in the ER: Common Scenarios CASE 1. Fast facts. Diagnosis. Management

Acute Respiratory Distress Syndrome (ARDS) An Update

Medical Treatment for acute Decompensated Heart Failure. Vlasis Ninios Cardiologist St. Luke s s Hospital Thessaloniki 2011

Pulmonary Pearls. Medical Pearls. Case 1: Case 1 (cont.): Case 1: What is the Most Likely Diagnosis? Case 1 (cont.):

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER:

Presenter: Steven Brust, HCS-D, HCS-H Product Manager, Home Health Coding Center

Hemodynamic Monitoring

Medication Policy Manual. Topic: Makena, hydroxyprogesterone caproate Date of Origin: March 28, 2011

Prenatal Exposure to Methyldopa Leading to Hypertensive Crisis and Cardiac Failure in a Neonate

SESSION D5. The Heart of the Matter: Cardiac Disease in Pregnancy Brad M. Dolinsky, MD, MFM

Asthma in Pregnancy, Labour and Postnatal Guidelines

Heart Failure Dr ahmed almutairi Assistant professor internal medicin dept

Composition Each ml of Ventol solution for inhalation contains 5 mg Salbutamol (as sulphate).

Hemodynamic Changes in Obstetric Anesthesia. Sonia Vaida PANA, Hershey, April 2009

ACUTE RESPIRATORY DISTRESS SYNDROME

Central Sleep Apnea Problem Based Learning Module

-Cardiogenic: shock state resulting from impairment or failure of myocardium

Mercy San Juan Medical Center. Preeclampsia and Other Hypertensive Disorders of Pregnancy

The dos and don ts των νέων Κατευθυντηρίων Οδηγιών της Ευρωπαϊκής Καρδιολογικής Εταιρείας Για την καρδιαγγειακή νόσο στην εγκυμοσύνη

PALS Pulseless Arrest Algorithm.

CASE PRESENTATION. By: Sarah Khalil Zeina Shamil Supervised By: DR.ABDULHAK AL_NUAIMI

Angina pectoris due to coronary atherosclerosis : Atenolol is indicated for the long term management of patients with angina pectoris.

BPD. Neonatal/Pediatric Cardiopulmonary Care. Disease. Bronchopulmonary Dysplasia. Baby Jane

7/4/2015. diffuse lung injury resulting in noncardiogenic pulmonary edema due to increase in capillary permeability

Myocardial Infarction: Left Ventricular Failure

LEFT HEART AND EXACERBATION OF LEFT HEART FAILURE

Supplemental Digital Content: Definitions Based on the International Classification of Diseases, Ninth Revision, Clinical Modification

You admitted a previously healthy nullipara at 36 weeks gestation who presented with new-onset periorbital edema and is found to have blood pressure

EDUCATIONAL COMMENTARY TRANSFUSION-RELATED ACUTE LUNG INJURY

Heart Failure (HF) Treatment

Complications of Acute Myocardial Infarction

Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine

Chapter 11: Respiratory Emergencies

Proceedings of the 34th World Small Animal Veterinary Congress WSAVA 2009

3 European Journal of Heart Failure 2016; 18,

Clinical Outcomes of Women with Peripartum Cardiomyopathy With and Without Preeclampsia: a Population-based Study

An Overview of Bronchopulmonary Dysplasia and Chronic Lung Disease in Infancy

Sample Case Study. The patient was a 77-year-old female who arrived to the emergency room on

Restrictive Pulmonary Diseases

Screening for Critical Congenital Heart Disease

Heart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output

Risk of Subsequent Pregnancy in Women with a History of Peripartum Cardiomyopathy Uri Elkayam, MD

Cardiovascular Images

Anatomy & Physiology

Study of the role of low dose magnesium Sulphate in Hypertensive Disorders of Pregnancy 1 2

Fetal Ductus Arteriosus: The Good, Bad, and the Ugly. Tet Abs Valve syndrome With PDA. Fetal Ductus Arteriosus. James C. Huhta, M.D.

Non-cardiogenic pulmonary edema: when to think and how to treat?

Information Often Given to the Nurse at the Time of Admission to the Postanesthesia Care Unit

Right-Sided Congestive Heart Failure Basics

Diagnosis & Management of Heart Failure. Abena A. Osei-Wusu, M.D. Medical Fiesta

Test Bank Pilbeam's Mechanical Ventilation Physiological and Clinical Applications 6th Edition Cairo

Transcription:

Postpartum pulmonary edema 157 Acute Postpartum Pulmonary Edema: A Case Report Min-Po Ho 1, Wing-Keung Cheung 2, Kaung-Chau Tsai 1 Acute pulmonary edema after pregnancy is rare. Pulmonary emobolism, pneumonia, aspiration and pulmonary edema are some of the potentially devastating causes that should be considered. We report a case of a previously healthy 45 year-old woman had pulmonary edema 3 hours after a normal vaginal delivery at a local clinic. Two days before admission, the patient had received tocolytic therapy to suppress premature labor. After medical treatment, her symptoms subsided and a chest radiograph showed resolution of pulmonary edema 12 hours later. She was discharged the next day in stable condition. Key words: postpartum, acute pulmonary edema, tocolytic agent Introduction Postpartum pulmonary edema is a rare clinical entity. Pulmonary edema of cardiac origin is a common medical condition that can range in severity from chronic, to subclinical to acute, with accompanying severe respirstory compromise. In a young, previously healthy postpartum patient, the differential diagnosis must be expanded to include some less prevalent casues, such as peripartum cardiomyopathy and cardiac failure secondary to tocolysis (1). Herein, we report a case of postpartum noncardiogenic pulmonary edema with respiratory distress after use of a tocolytic agent. Case Report A 45-year-old woman G 2 P 1 presented to the emergency department (ED) with progressive dyspnea 3 hours after normal vaginal delivery at a local clinic. She had no remarkable cardiac disease, hypertension, respiratory tract infection or significant allergies. She had no family history of cardiac or respiratory disease. Two days previously, the patient had received tocolytic therapy to suppress premature labor. Her baby had been delivered by spontaneous vaginal delivery at 37 weeks. The patient denied visual changes, headache, and hand and face swelling. No lower limb swelling was noted. On physical examination, she had marked respiratory distress and chest auscultation revealed basal crackles with reduced breath sounds bilaterally. The rest of the physical examination was unremarkable. Her blood pressure was 110/68 mmhg, heart rate 120 beats/ minute, respiratory rate 24 breaths/min, body temperature 37.4, and oxygen saturation on room air 89%. Electrocardiography showed sinus tachycardia. H e r c h e s t r a d i o g r a p h r e v e a l e d i n c r e a s e d infiltration bilaterally (Fig. 1), compatible with acute pulmonary edema. Laborotary data showed mild leukocytosis and cardiac makers, C-reactive protein and D-dimer were within the normal range. A cardiologist was consulted and immediate Received: November 25, 2009 Accepted for publication: January 11, 2010 From the 1 Department of Emergency Medicine, 2 Department of Medical Imaging, Far Eastern Memorial Hospital Address reprint requests and correspondence: Dr. Kaung-Chau Tsai Department of Emergency Medicine, Far Eastern Memorial Hospital 21 Section 2, Nanya South Road, Panchiao 220, Taipei County, Taiwan (R.O.C.) Tel: (02)89667000 ext 1122 Fax: (02)89660454 E-mail: hikali@mail.femh.org.tw

158 J Emerg Crit Care Med. Vol. 21, No. 3, 2010 Fig. 1 Chest radiograph showing increased infiltration over both lungs, compatible with acute pulmonary edema echocardiography showed normal ventricular function with an ejection fraction of 66%, trace mitral and tricuspid regurgitation, normal wall motion and no pericardial effusion, clots or shunt. Arterial blood gas analysis showed the ph was 7.43, Pa CO 2 38 mmhg, PaO 2 59 mmhg and HCO 2 28 mmol/l on 100% oxygen. Initial resuscitative measures in the ED included oxygen administration by nonrebreather mask, which increased her oxygen saturation to 95%. Furosemide was administered intravenously at a dose of 40 mg. After aggressive medical treatment, her symptoms gradually subsided and a repeat chest radiograph (Fig. 2) taken 12 hours later showed resolution of pulmonary edema. Urine output was 1700 ml seven hours after initial treatment and she showed considerable improvement in her symptoms. Urinalysis revealed no evidence of urinary tract infection. Blood cultures were negative. The patient received close observation in the ED overnight with monitoring of oxygen saturation, blood pressure and electrocardiography. The next day, 12 hours after arrival in the ED, her pulmonary edema was largely resolved and oxygen saturation was 98% on room air. She was discharged in stable condition. The patient was doing well at follow-up 9 months after discharge. Discussion It has been estimated that 0.08% of pregnancies are complicated by acute pulmonary edema. Despite the low rate of occurrence, there is significant morbidity, and mortality has been reported with this diagnosis (1). The most common contributing factors include underlying cardiac disease, the use of tocolytic agents, iatrogenic fluid overload and preeclampsia (1,2). According to Dunne et al 1, the differential diagnosis for postpartum dyspnea includes the following: without pulmonary edema pulmonary embolism, amniotic fluid embolism, pneumonia, foreign body aspiration, psychogenic dyspnea with pulmonary edema cardiogenic: peripartum cardiomyopathy, preecclampsia-related heart failure, underlying cardiac disease, myocardial ischemia and sepsis with poor cardiac output noncardiogenic: iatrogenic fluid overload, thyroid disease, tocolytic therapy or medication related

Postpartum pulmonary edema 159 Fig. 2 Twelve hours later, a chest radiograph shows resolution of pulmonary edema sepsis, acute respiratory distress syndrome H o w e v e r, o u r investigation r u led o u t pulmonary embolism, amniotic fluid embolism, pneumonia and sepsis. Our patient was treated with a tocolytic agent (β-adrenergic agonist) for 2 days. According to a physician from the local clinic, iatrogenic fluid overload could be ruled out because there was no history of administration of large amounts of fluid before or during delivery. Three hours after a normal vaginal delivery, our patient suffered from progressive dyspnea. Cardiac disease was ruled out as there was no evidence of abnormal cardiac markers or abnormalities on the echocardiogram. Tocolytic agents, which include terbutaline, ritodrine, salbutamol, and isoxsuprine, suppress premature uterine contractions during pregnancy. These β-adrenergic agonists increase intracellular cyclic adenosine monophosphate levels, thus decreasing muscular contraction. Pulmonary edema has been reported in association with the short-term use of β-adrenergic agonists (average 54 hours) in late pregnancy with an incidence of approximately 0 to 4.4% (3,4). Pulmonary edema occurs during current or recent (< 24 hours) usage or appears less than 12 hours postpartum when tocolytic therapy has failed (5). In previous reports, using acute tocolysis therapy to prolong pregnancy in patients hospitalized with preterm labor at 32 to 34 weeks gestation was associated with improved neonatal outcomes (6). At 32 weeks, tocolysis yielded the lowest total number of adverse maternal and neonatal events. At 36 weeks it is probably better not to use tocolysis (7). Generally, tocolytic therapy is not recommended after 34 weeks gestation to avoid unnecessary complications, such as noncardiogenic pulmonary edema, as in our patient. Clinical features and radiographic appearances are generally indistinguishable from other causes of pulmonary edema and adult respiratory distress syndrome. Typical manifestations include dyspnea, chest discomfort, tachypnea, and hypoxemia (5,8). Unlike pulmonary edema due to congestive heart failure, cardiomegaly and pulmonary vascular redistribution are generally absent in cases that are drug-related (8). Fluid overload purportendly occurs in 70% of patients. Rapid clinical improvement (< 24 hours) is normal, although a small percentage of patients may need mechanical ventilatory support. Mortality is low for both the mother and fetus (5). These drugs may induce pulmonary edema in pregnant women, although this effect

160 J Emerg Crit Care Med. Vol. 21, No. 3, 2010 has not been observed with treatment of asthma in the nonpregnant state. This condition appears to be a form of noncardiac pulmonary edema, possibly caused by drug-induced fluid retention, superimposed on that normally occurring in the gravid state. This syndrome is unassociated with evidence of myocardial dysfunction and responds readily to diuretics and oxygen (9). In conclusion, acute pulmonary edema in a previously healthy woman who has recently given birth is an uncommon clinical scenario with some life-threatening complications. No matter what the underlying pathology, prompt appropriate resuscitation is always the first priority. References 1. Dunne C, Meriano A. Acute postpartum pulmonary edema in a 23-year-old woman 5 days after cesarean delivery. CJEM 2009;11:178-81. 2. Sciscione AC, Ivester T, Largoza M, Manley J, Shlossman P, Colmorgen GH. Acute pulmonary e d e m a i n p r e g n a n c y. O b s t e t G y n e c o l 2003;101:511-5. 3. Pisani RJ, Rosenow EC. Pulmonary edema associated with tocolytic therapy. Ann Intern Med 1989;110:714-8. 4. Russi EW, Spaetling L, Gmur J, Schneider H. High permeability pulmonary edema (ARDS) during tocolytic therapy: a case report. J Perinat Med 1988;16:45-9. 5. R e e d C R, G l a u s e r F L. D r u g-i n d u c e d noncardiogenic pulmonary edema. Chest 1991;100:1120-4. 6. Elliott JP, Istwan NB, Rhea DJ, Desch CN, Stanziano GJ. The impact of acute tocolysis on neonatal outcome in women hospitalized with preterm labor at 32 to 34 weeks gestation. Am J Perinatol 2009;2:123-8. 7. Macones GA, Bader TJ, Asch DA. Optimising maternal-fetal outcomes in preterm labour: a decision analysis. Br J Obstet Gynaecol 1998;5:541-50. 8. Lee-Chiong T Jr, Matthay RA. Drug-induced pulmonary edema and acute respiratory distress syndrome. Clin Chest Med. 2004;25:95-104. 9. Tavel ME, Le Jemtel TH. Differential diagnosis of postpartum pulmonary edema. Chest 1995;108:1479.

161 1 2 1 45 3 2 12 X 98 11 25 99 1 11 1 2 21 (02)89667000 1122 (02)89660454 E-mail: hikali@mail.femh.org.tw